“Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis”

Abstract Epidemiological studies have evaluated the association between maternal methylenetetrahydrofolate reductase (MTHFR) C677T, A1298C and methionine synthase reductase (MTRR) A66G polymorphisms and risk of neural tube defects (NTDs) in offspring. However, the results from the published studies...
Ausführliche Beschreibung

Abstract Epidemiological studies have evaluated the association between maternal methylenetetrahydrofolate reductase (MTHFR) C677T, A1298C and methionine synthase reductase (MTRR) A66G polymorphisms and risk of neural tube defects (NTDs) in offspring. However, the results from the published studies on the association between these three polymorphisms and NTD risk are conflicting. To derive a clearer picture of association between these three maternal polymorphisms and risk of NTD, we performed meta-analysis. A comprehensive search was conducted to identify all case–control studies of maternal MTHFR and MTRR polymorphisms and NTD risk. We used odds ratios (ORs) with 95 % confidence intervals (CIs) to assess the strength of the association. Overall, we found that maternal MTHFR C677T polymorphism ($ OR_{TvsC} $ =1.20; 95 % CI = 1.13–1.28) and MTRR A66G polymorphism ($ OR_{GvsA} $ = 1.21; 95 % CI = 0.98–1.49) were risk factors for producing offspring with NTD but maternal MTHFR A1298C polymorphism ($ OR_{CvsA} $ = 0.91; 95 % CI = 0.78–1.07) was not associated with NTD risk. However, in stratified analysis by geographical regions, we found that the maternal C677T polymorphism was significantly associated with the risk of NTD in Asian ($ OR_{TvsC} $ = 1.43; 95 % CI: 1.05–1.94), European ($ OR_{TvsC} $ = 1.13; 95 % CI: 1.04–1.24) and American ($ OR_{TvsC} $ = 1.26; 95 % CI: 1.13–1.41) populations. In conclusion, present meta-analysis supports that the maternal MTHFR C677T and MTRR A66G are polymorphisms contributory to risk for NTD. Ausführliche Beschreibung